Spyre Therapeutics, Inc. ($SYRE)
Filing Information
| Accession Number | 0001758363-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 4, 2026 |
| Document | View SEC Filing |
Transactions
2
Total Shares
15,000
Total Value
$739,912.32
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Apr 1, 2026 | Sale | 12,344 | $49.20 | $607,324.80 | 630,196 | Direct | โ | View Details | |
Director | Common Stock | โ | Apr 1, 2026 | Sale | 2,656 | $49.92 | $132,587.52 | 627,540 | Direct | โ | View Details |